Loading clinical trials...
Loading clinical trials...
Optimization and Individualization of Diagnostic Scintigraphy Protocol and Minimally Invasive Radio-guided Parathyroid Surgery Using Quantitative Analysis of Scintigraphy Results on Hybrid SPECT-CT Imaging
Conditions
Interventions
Conventional (dual-phase) SPECT/CT
Multi-phase SPECT/CT
+2 more
Locations
1
Czechia
University Hospital Ostrava
Ostrava, Moravian-Silesian Region, Czechia
Start Date
May 1, 2016
Primary Completion Date
November 30, 2020
Completion Date
December 31, 2020
Last Updated
December 7, 2022
NCT07081997
NCT07462195
NCT04785443
NCT07382973
NCT07301892
NCT07043166
Lead Sponsor
University Hospital Ostrava
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions